Bioventix PLC (AIM:BVXP)
London · Delayed Price · Currency is GBP · Price in GBX 1,705.00
-25.00 (-1.45%)
Sep 4, 2026, 4:36 PM GMT
Bioventix Market Cap
Bioventix has a market cap or net worth of 90.39 million as of September 4, 2026. Its market cap has decreased by -29.96% in one year.
Market Cap
90.39M
Enterprise Value
85.09M
Revenue
12.54M
Ranking
n/a
PE Ratio
12.31
Stock Price
1,705.00
ChartMarket Cap Chart
Since April 8, 2010, Bioventix's market cap has increased from 9.85M to 90.39M, an increase of 817.90%. That is a compound annual growth rate of 14.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 90.39M | -9.19% |
| Dec 31, 2025 | 99.53M | -39.94% |
| Dec 31, 2024 | 165.72M | -26.16% |
| Dec 29, 2023 | 224.45M | 7.98% |
| Dec 30, 2022 | 207.85M | 17.35% |
| Dec 31, 2021 | 177.12M | -22.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Avacta Group | 309.15M |
| PureTech Health | 306.71M |
| Scancell Holdings | 115.77M |
| Faron Pharmaceuticals Oy | 77.09M |
| 4basebio | 73.81M |
| Poolbeg Pharma | 65.50M |
| Ondine Biomedical | 59.75M |
| Sareum Holdings | 48.50M |